ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA. J Popl Ther Clin Pharmacol 2024, 31 (9), 731-740. https://doi.org/10.53555/nhwgvd87.